Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
Frontiers Decoding TROP2 in breast cancer: significance, clinical implications, and therapeutic advancements
Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer
Frontiers Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer
Cancers, Free Full-Text
Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors [PeerJ]
Cancers, Free Full-Text
Frontiers Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer
Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression
Predictive Biomarkers of Neoadjuvant Chemotherapy in Breast Cancer
Cells, Free Full-Text
PDF) Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
Cells, Free Full-Text